Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Interdisciplinary Hemophilia A Education: Conversation Between a Hematologist and a Physical Therapist
  • CME
  • CE

Credits Available
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Pharmacists: 0.25 contact hours (0.025 CEUs)
Released: March 16, 2022 Expiration: March 15, 2023
Start Activity
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

In partnership with the
Supported by an educational grant from
Genentech, a member of the Roche Group
Susan Knight, PT, PCS
Guy A. Young, MD

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Plan effective hemophilia care that improves patient adherence and quality of life, considering clinical data on new nonfactor prophylaxis therapies vs current factor replacement standards
  • Equip adolescents/young adults and other appropriate patients with hemophilia A, through counseling and education, to assume autonomous care for much of their hemophilia prophylaxis

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty

Susan Knight, PT, PCS

Physical Therapist
Los Angeles, California

Susan Knight, PT, PCS, has no relevant conflicts of interest to disclose.
Guy A. Young, MD

Professor of Pediatrics
Director,
Hemostasis and Thrombosis Center
Children's Hospital Los Angeles
University of Southern California Keck School of Medicine
Los Angeles, California

Guy Young, MD, has disclosed that he has received consulting fees from Apcintex, BioMarin, Genentech/Roche, Grifols, Novo Nordisk, Pfizer, Rani, Sanofi Genzyme, Spark, Takeda, and UniQure and funds for research support from Genentech/Roche, Grifols, and Takeda.

Staff

Shara Pantry, PhD

Associate Scientific Director

Shara Pantry, PhD, has no relevant conflicts of interest to report.
Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant conflicts of interest to report.
Kristen Morrow, PhD

Editorial Contributor

Kristen Morrow, PhD, has no relevant conflicts of interest to report.
Kristen Rosenthal, PhD

Associate Director, Scientific Services

Kristen M. Rosenthal, PhD, has no relevant conflicts of interest to report.
Timothy A. Quill, PhD

Associate Director, Scientific Services

Timothy A. Quill, PhD, has no relevant conflicts of interest to report.
June Wasserstrom

Director, CME Program Development

June Wasserstrom has no relevant conflicts of interest to report.
Kevin Obholz, PhD

Senior Director, Educational Strategy

Kevin Obholz, PhD, has no relevant conflicts of interest to report.
Kristi Kay Orbaugh, MSN, NP, AOCNP

Adult Oncology Nurse Practitioner
Community Hospital Oncology Physicians
Indianapolis, Indiana

Kristi Orbaugh, MSN, NP, AOCNP has disclosed that she has served as a speaker for AstraZeneca, Bristol-Myers Squibb, DSI, Gilead Sciences, Lilly, Morphosys, Pfizer, Regeneron, and Sanofi.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This educational program is intended for all healthcare professionals across multiple disciplines and specialties who care for patients with hemophilia A, including hematologists, nurse practitioners, pharmacists/managed care professionals, surgeons, pathologists, and social workers/mental health professionals.

Goal

The goal of this program is to improve the knowledge, competence, and performance of healthcare professionals involved in the management of patients with hemophilia A, in the benefits of prophylaxis therapy and adherence to treatment regimens for patients with hemophilia A.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 0.25 contact hours (0.025 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-082-H01-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 100% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 16, 2022, through March 15, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Interdisciplinary Hemophilia A Education: Conversation Between a Hematologist and a Physical Therapist
  • CME
  • CE

Loading...
Watch this interactive module to gain a better understanding of the role of physical therapists in caring for patients with hemophilia.
Susan Knight, PT, PCS
Guy A. Young, MD
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Pharmacists: 0.25 contact hours (0.025 CEUs)
Released: March 16, 2022 Expiration: March 15, 2023

Related Content

On-demand webcast of a live symposium at THSNA 2022 with experts discussing the management of immune thrombocytopenia, from Clinical Care Options (CCO)

David J. Kuter, MD, DPhil
Program Director
Catherine M. Broome, MD Cindy Neunert, MD, MSCS
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: September 15, 2022 Expired: September 14, 2023

Downloadable slideset on the key teaching points and considerations in the management of ITP, from Clinical Care Options (CCO)

Catherine M. Broome, MD David J. Kuter, MD, DPhil Cindy Neunert, MD, MSCS Released: August 26, 2022

A short downloadable slideset touching on key points in the treatment of hemophilia A & B, including extended half-life factor replacement, nonfactor therapies, and therapies to restore the hemostatic balance, from Clinical Care Options (CCO)

Glaivy Batsuli, MD Allison Wheeler, MD, MSCI Guy A. Young, MD Released: August 26, 2022

Downloadable slideset on the initial treatment considerations in the management of ITP, from Clinical Care Options (CCO)

Cindy Neunert, MD, MSCS Released: August 19, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings